Steven King

President and Chief Executive Officer

​

Paul Lytle

EVP, Chief Financial Officer

​

Nicole F. Steinmetz, Ph.D.

Acting Chief Scientific Officer

​

Lisa Stepp, Ph.D.

VP, Patient and Government Engagement

​

Shelley Fussey, Ph.D.

VP, Intellectual Property

​

Anthony E. Maida III, Ph.D.

Clinical Advisor, Translational Medicine

​

Joseph Shan, MPH

Head of Clinical Operations

​

Marvin Garovoy, MD

Head of Medical Immuno-Oncology

​

Cyril Empig, Ph.D.

Head of Vaccine Development

​

Jay Carlson

Sr. Manager, Investor Relations

​

​